Growth Metrics

Cytek Biosciences (CTKB) Raw Materials (2020 - 2026)

Cytek Biosciences filings provide 6 years of Raw Materials readings, the most recent being $20.4 million for Q4 2025.

  • On a quarterly basis, Raw Materials fell 9.43% to $20.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.4 million, a 9.43% decrease, with the full-year FY2025 number at $20.4 million, down 9.43% from a year prior.
  • Raw Materials hit $20.4 million in Q4 2025 for Cytek Biosciences, down from $24.7 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $42.2 million in Q1 2023 to a low of $15.4 million in Q3 2021.
  • Median Raw Materials over the past 5 years was $25.8 million (2022), compared with a mean of $26.9 million.
  • Biggest five-year swings in Raw Materials: surged 99.18% in 2023 and later crashed 36.81% in 2024.
  • Cytek Biosciences' Raw Materials stood at $17.3 million in 2021, then soared by 56.0% to $26.9 million in 2022, then soared by 32.66% to $35.7 million in 2023, then crashed by 36.81% to $22.6 million in 2024, then fell by 9.43% to $20.4 million in 2025.
  • The last three reported values for Raw Materials were $20.4 million (Q4 2025), $24.7 million (Q3 2025), and $24.9 million (Q2 2025) per Business Quant data.